Published in Gut on January 01, 2005
The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol (2012) 1.13
Role of Toll-like receptors in Helicobacter pylori infection and immunity. World J Gastrointest Pathophysiol (2014) 0.86
Generation and Characterization of Mouse Hybridomas Secreting Monoclonal Antibodies Specific for Human IgG3. Avicenna J Med Biotechnol (2009) 0.79
Production and characterization of mouse monoclonal antibodies recognizing multiple subclasses of human IgG. Avicenna J Med Biotechnol (2010) 0.77
Helicobacter pylori-Mediated Protection from Allergy Is Associated with IL-10-Secreting Peripheral Blood Regulatory T Cells. Front Immunol (2016) 0.76
Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver (2013) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res (1991) 19.71
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 4.26
Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest (1994) 3.40
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut (1995) 2.52
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol (1998) 1.98
A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch Med Res (2001) 1.85
Antibody to Campylobacter pylori in families of index children with gastrointestinal illness due to C pylori. Lancet (1987) 1.73
Diagnosis of Helicobacter pylori infection in adult and pediatric patients by using Pyloriset, a rapid latex agglutination test. J Clin Microbiol (1992) 1.72
Helicobacter pylori colonization in early life. Pediatr Res (1999) 1.68
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
The effect of measurement error on the determination of Helicobacter pylori prevalence. Epidemiology (1997) 1.49
Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol (1997) 1.48
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Subclass distribution of rubella virus-specific immunoglobulin G. J Clin Microbiol (1985) 1.46
Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. Eur J Clin Microbiol Infect Dis (1995) 1.44
Enzyme-linked immunosorbent assay for detection of immunoglobulin A and G antibodies to Campylobacter pylori. Eur J Clin Microbiol Infect Dis (1988) 1.44
Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin Exp Immunol (1991) 1.43
Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut (1994) 1.40
Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol (1992) 1.39
Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol (1997) 1.38
Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS (2003) 1.33
Helicobacter pylori infection in healthy people: a dynamic process? Gut (1991) 1.31
Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol (1997) 1.22
IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol (1998) 1.18
Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl (1997) 1.14
Transient and persistent Helicobacter pylori colonization in Native American children. J Clin Microbiol (2003) 1.14
Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect Immun (1996) 1.13
Helicobacter pylori infection in the young in Bangladesh: prevalence, socioeconomic and nutritional aspects. Int J Epidemiol (1996) 1.04
Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1992) 1.03
Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer. J Clin Microbiol (2000) 1.02
Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health (2000) 1.02
Helicobacter pylori infection may undergo spontaneous eradication in children: a 2-year follow-up study. J Pediatr Gastroenterol Nutr (1998) 0.99
Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity. J Clin Microbiol (1987) 0.97
Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population. Am J Epidemiol (1996) 0.97
Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun (2000) 0.92
Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections. World J Gastroenterol (2002) 0.84
Use of commonly prescribed antibiotics is not associated with prevalence of Helicobacter pylori infection in adults. Scand J Gastroenterol (1997) 0.81
Interactions between Helicobacter pylori and the local mucosal immune system. Scand J Gastroenterol Suppl (1991) 0.81
Helicobacter pylori antibody titres in serum, plasma and successively thawed specimens: implications for epidemiological and clinical studies. J Clin Pathol (1996) 0.80
Normal interleukin-12 production in individuals with antibodies to Helicobacter pylori. APMIS (1997) 0.80
Effects of interleukin-4 and interferon-gamma on the secretion of IgG4 from human peripheral blood mononuclear cells. Allergy (1993) 0.79
Systemic humoral response to Helicobacter pylori in children and adults. Arch Immunol Ther Exp (Warsz) (1998) 0.77
Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response. Microbiol Immunol (1990) 0.76
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene (1995) 2.91
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet (1997) 2.77
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
Energy expended playing Xbox Kinect™ and Wii™ games: a preliminary study comparing single and multiplayer modes. Physiotherapy (2012) 2.34
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun (2004) 1.94
Crucial importance of PKC-beta(I) in LFA-1-mediated locomotion of activated T cells. Nat Immunol (2001) 1.94
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol (2005) 1.56
Helicobacter pylori increases proliferation of gastric epithelial cells. Gut (1996) 1.53
Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol (2000) 1.51
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47
Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol (1998) 1.45
Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol (2003) 1.45
Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes (1995) 1.43
Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain. Endoscopy (2001) 1.43
Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut (1994) 1.40
Determination of norepinephrine apparent release rate and clearance in humans. Life Sci (1979) 1.37
An HLA-D region restriction fragment length polymorphism associated with celiac disease. J Exp Med (1986) 1.32
Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol (1999) 1.26
The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut (2005) 1.22
An extended HLA-D region haplotype associated with celiac disease. Proc Natl Acad Sci U S A (1988) 1.21
Review of computerized decision support systems for oral anticoagulation management. Br J Haematol (1998) 1.19
Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women. Climacteric (2006) 1.18
Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team. AIDS (1998) 1.18
St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol (2002) 1.18
Identification and characterization of a metalloprotease activity from Helicobacter pylori. Infect Immun (1997) 1.17
Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol (2000) 1.17
Retinoid X receptor alpha forms tetramers in solution. Proc Natl Acad Sci U S A (1995) 1.17
Refractory celiac disease. Gastroenterology (2000) 1.15
Cranial epidural empyema with osteomyelitis caused by actinomyces, CT, and MRI appearance. Clin Imaging (2000) 1.14
Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies. J Immunol Methods (1993) 1.13
Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection. Ir J Med Sci (1993) 1.09
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS (2000) 1.07
A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation. J Clin Pathol (2003) 1.07
Protein kinase C and the cytoskeleton. Cell Signal (1998) 1.05
The thioredoxin system of Helicobacter pylori. J Biol Chem (2000) 1.02
H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol (1998) 1.01
The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology (2000) 1.00
Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 0.99
A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer (2001) 0.98
Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension (1981) 0.97
Celiac disease and other nutrient related injuries to the gastrointestinal tract. Am J Gastroenterol (1994) 0.97
pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol (1996) 0.96
Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78. J Biol Chem (1995) 0.96
Convenience store robberies in selected metropolitan areas. Risk factors for employee injury. J Occup Environ Med (1997) 0.95
PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma. Br J Cancer (2011) 0.95
Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum. Gut (1994) 0.95
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut (1996) 0.95
Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun (1998) 0.94
The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma. Br J Cancer (2012) 0.93
Microalbuminuria in inflammatory bowel disease. Gut (1994) 0.93
RAG1 and RAG2 expression in human intestinal epithelium: evidence of extrathymic T cell differentiation. Eur J Immunol (1995) 0.93
Inside the crawling T cell: leukocyte function-associated antigen-1 cross-linking is associated with microtubule-directed translocation of protein kinase C isoenzymes beta(I) and delta. J Immunol (1998) 0.91
Diagnostic and therapeutic ERCP: a large single centre's experience. Ir J Med Sci (2002) 0.90
Histogenesis of malignant histiocytosis of the intestine. Gastroenterology (1987) 0.89
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin Exp Immunol (2002) 0.89
Helicobacter pylori activates the early growth response 1 protein in gastric epithelial cells. Infect Immun (2004) 0.88
Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease. Ir J Med Sci (2000) 0.88
Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys (1990) 0.88
Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy. Dis Esophagus (2005) 0.88
Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes require new protein synthesis by epithelial cells. Gut (1997) 0.87
Decreased intestinal CYP3A in celiac disease: reversal after successful gluten-free diet: a potential source of interindividual variability in first-pass drug metabolism. Clin Pharmacol Ther (1996) 0.87
High sensitivity cytokine detection in acute coronary syndrome reveals up-regulation of interferon gamma and interleukin-10 post myocardial infarction. Clin Immunol (2009) 0.86
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. Antivir Ther (2001) 0.86
Endocinch treatment for GORD: where it stands. Gut (2005) 0.86
Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA Transcripts: implications for extrathymic T-cell differentiation. Hum Immunol (1997) 0.86
Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinoma. Digestion (1990) 0.86
Increased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation? Gut (1996) 0.85
TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol (1996) 0.85
Vitamin C enhances chemosensitization of esophageal cancer cells in vitro. J Chemother (2005) 0.84
Up-regulation of CD44 and ICAM-1 expression on gastric epithelial cells by H. pylori. APMIS (1995) 0.84
EndoCinch treatment for gastro-oesophageal reflux disease. Digestion (2008) 0.84
Comparative locomotory behavior of T lymphocytes versus T lymphoma cells on flat and grooved surfaces. Ann Biomed Eng (2003) 0.83
Adhesion molecule expression on gastric intra-epithelial lymphocytes of patients with Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 0.83
Levels of interpopulation differentiation among different functional classes of immunologically important genes. Genes Immun (2006) 0.83
Cutting edge: protein kinase C beta expression is critical for export of Il-2 from T cells. J Immunol (2001) 0.83
Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease. Mediators Inflamm (2001) 0.82
Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut (1996) 0.82
Increased pigmentation in scleroderma. J Rheumatol (1996) 0.82
Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol (1997) 0.82
Characterization of tumour necrosis factor-alpha genetic variants and mRNA expression in patients with severe sepsis. Int J Immunogenet (2008) 0.81
A calcified lung tumour and microcytic anaemia in a young woman: partial expression of the Carney triad. Surgeon (2008) 0.81
Reforming the EU environment for clinical trials: what are the challenges? QJM (2013) 0.81